Navigation Links
Max Healthcare Announces Organizational Changes
Date:11/10/2011

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2011 /PRNewswire/ -- Max Healthcare, India's first comprehensive provider of standardized, seamless and world-class healthcare services, today announced organizational changes that include Dr. Ajay Bakshi joining the Company as Chief Executive Officer, effective November 1, 2011. The Company also named Dr. Abha Aggarwal to the position of Chief Operating Officer and announced that Mr. Ranvir Bhandari would be taking the additional role of Chief Service Officer.

(Logo:  http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

Commenting on the new appointments, Max Healthcare Managing Director Rahul Khosla said: "In today's world it is very important to harness and leverage on a mixture of different domain expertise." Instead of having one person who takes every decision, the company wants accountability to be clear but the process of making decisions should invite as much expertise as possible. 

Prior to his new assignment, Dr. Bakshi was as an associate principal with McKinsey & Company. Dr. Agrawal served as the Chief Medical Officer and Chief Informatics Officer at Kings County Hospital Centre in New York. 

Mr. Analjit Singh, founder of the Max Group, said that he strongly believes the new leadership team at Max Healthcare will bring in the youth and vigor needed to successfully run and grow a large healthcare business.  He looks forward to a progressive new phase in Max Healthcare's revolution towards becoming India's most admired healthcare providers.

About Max Healthcare

With over 1100 beds, 12 hospitals, 1500 physicians and 3000 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 275 ICU beds and most advanced technologies makes it one of the best hospitals in India.  For more information please visit www.maxhealthcare.in.  

About Max Neeman International

Max Neeman International is a leading India CRO offering services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 & ISO 27001:2005 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 31 cities with 6 regional offices. For more information please visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges
2. ConvaTec Healthcare Announces 2011 Third Quarter Earnings Call
3. HeartWare to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences
5. U.S. Soldiers and Veterans at Home and Abroad Touched by Lifesaving Products From Philips Healthcare
6. Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthcare Conference
7. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Henry Schein to Present at Credit Suisse 2011 Healthcare Conference
9. LCA-Vision to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
10. Masimo to Present at Lazard Capital Markets Healthcare Conference
11. Allied Healthcare Products Reports First Quarter Loss on Sales Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017  Kratom leaves, from a ... are often used to prepare tea-like beverages and ... million Americans annually to increase alertness, enhance well-being ... for minor aches and pains. PinneyAssociates, review of ... to assist FDA and DEA in determining the ...
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... , Suiza, 18 de enero de 2017  Hoy, ... lanzaron Access Accelerated, una iniciativa global para avanzar el ... y atención en países de renta baja y baja-media ... alcanzado un punto de crisis, particularmente en países de ... 80 por ciento de las muertes relacionadas con NCD. ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
(Date:1/19/2017)... ... 2017 , ... The CHP suggests that California drivers can avoid hydroplaning as ... and increasing the space between themselves and other vehicles, according to a January 3 ... R. Hassanlou notes that, rain or shine, drivers should always incorporate safe driving practices ...
(Date:1/19/2017)... ... January 19, 2017 , ... The 21st Century Cures Act’s Impact ... Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          ... Act in order to thrive this year? , The passage of the act means ...
(Date:1/19/2017)... ... January 19, 2017 , ... Infinity® Massage Chairs announced today ... implement new sales and marketing strategies. Grover comes with a total of 15 years ... a half years as Executive Vice President of Direct Sales at Traeger® Wood Pellet ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for ... people know that popular cosmetic fillers can enhance earlobes and rejuvenate ... director of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. ...
Breaking Medicine News(10 mins):